ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0311

Ultra High‐frequency Ultrasound (UHFUS) of Labial Glands in Primary Sjögren’s Syndrome: Serological and Histological Correlations

Giovanni Fulvio1, Francesco Ferro1, Rossana Izzetti2, Gianmaria Governato1, Silvia Fonzetti1, Gaetano La Rocca1, Valentina Donati3, Davide Caramella4, Marta Mosca5 and Chiara Baldini6, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2University of Pisa, Unit of Dentistry and Oral Surgery, Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, Pisa, Italy, 3AOUP, Unit of Pathological Anatomy, Pisa, Italy, 4University of Pisa, 3Diagnostic and Interventional Radiology, Department of Translational Research and of New Technologies in Medicine and Surgery, Pisa, Italy, 5Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6University of Pisa, Pisa, Italy

Meeting: ACR Convergence 2021

Keywords: Sjögren's syndrome, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Last‐generation ultra high‐frequency ultrasound (UHFUS) transducers are highly sensitive tools potentially able to open new avenues for the identification of imaging biomarkers. Recently UHFUS has been applied to the study of labial salivary glands (LSG) in patients with suspected primary Sjögren’s syndrome (pSS) showing a good diagnostic accuracy in identifying pSS from no-SS sicca. Objective:1. to assess the association between UHFUS scoring and LSG histology in patients with established pSS; 2. to explore the association between LSG-UHFUS scoring and anti-Ro antibody specificity (i.e. both anti-Ro60 and Ro52 or isolated anti-Ro52 and anti-Ro60 antibodies).

Methods: Out of a cohort of 207 patients who underwent a UHFUS guided LSG biopsy for suspected pSS (Jan 2018-Apr 2021), we identified 92 patients with an established newly diagnosed pSS (ACR/EULAR 2016 criteria). Patients’ clinical, biological and histological features were collected. The anti-Ro antibody specificity and titer were determined by immunoblotting. UHFUS of LSG was performed by using VEVO MD, equipped with a 70 MHz probe, evaluating parenchymal inhomogeneity (score 0-3). For each of the LSG specimens number of foci, focus score (FS) and ectopic lymphoid structures (ELS) were assessed.

Results: We included a total of 92 pSS patients: 41 (44.6%) with anti-Ro60 and anti-Ro52, 6 (6.5%) with anti-Ro60 alone, 25 (27.2%) with anti-Ro52 alone, and 20 (21.7%) with neither antibody. A UHFUS score 1 was observed in 32 (34.8%), a UHFUS score 2 in 47 (51.1%) and a UHFUS score 3 in 13 (14.1%) pSS patients. The UHFUS scoring was equally distributed within the four serotype subgroups; however, we observed a moderate correlation (r=0.300, p=0.01) between the UHFUS scoring and the anti-Ro60 titer. UHFUS score correlated also with IgG levels and with parotid and submandibular US (p< 0.05). No correlation was observed between UHFUS and ESSPRI, salivary flow and ocular tests. Regarding LSG histology, the higher was the UHFUS grading, the higher were: the number of foci (foci, mean (S.D) : 2.6 (2.8) in UHFUS-score 1 vs 5.9 (3.3) in UHFUS-score 3, p=0.001), the FS (FS, mean (S.D): 1.3 (1.2) in UHFUS-score 1 vs 2.1 (0.9) in UHFUS-score 3, p=0.01) and the number of ELS (ELS, mean (S.D): 0.9 (1.1) in UHFUS-score 1 vs 2.5 (1.9) in UHFUS-score 3, p=0.01). Noteworthy, out of the 13 patients with a UHFUS-score 3, 12/13 presented at least one ELS in their biopsies (p=0.01). UHFUS score-3 showed a specificity of 97.1% and a positive predictive value of 92.3% in the evaluation of ELS in LSGs.

Conclusion: UHFUS of LSG appeared significantly associated with serological and histological findings in pSS and may have a role in patients’ stratification.


Disclosures: G. Fulvio, None; F. Ferro, None; R. Izzetti, None; G. Governato, None; S. Fonzetti, None; G. La Rocca, None; V. Donati, None; D. Caramella, None; M. Mosca, None; C. Baldini, None.

To cite this abstract in AMA style:

Fulvio G, Ferro F, Izzetti R, Governato G, Fonzetti S, La Rocca G, Donati V, Caramella D, Mosca M, Baldini C. Ultra High‐frequency Ultrasound (UHFUS) of Labial Glands in Primary Sjögren’s Syndrome: Serological and Histological Correlations [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/ultra-high%e2%80%90frequency-ultrasound-uhfus-of-labial-glands-in-primary-sjogrens-syndrome-serological-and-histological-correlations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultra-high%e2%80%90frequency-ultrasound-uhfus-of-labial-glands-in-primary-sjogrens-syndrome-serological-and-histological-correlations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology